BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23232798)

  • 1. Advanced psychometric analysis and the Alzheimer's Disease Neuroimaging Initiative: reports from the 2011 Friday Harbor conference.
    Mungas D; Crane PK; Gibbons LE; Manly JJ; Glymour MM; Jones RN
    Brain Imaging Behav; 2012 Dec; 6(4):485-8. PubMed ID: 23232798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
    Weiner MW; Veitch DP
    Alzheimers Dement; 2015 Jul; 11(7):730-3. PubMed ID: 26194308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
    Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.
    Lin Y; Shan PY; Jiang WJ; Sheng C; Ma L
    Neurol Sci; 2019 Jan; 40(1):41-49. PubMed ID: 30397816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach.
    Posner HB; Cano S; Carrillo MC; Selnes O; Stern Y; Thomas RG; Zajicek J; Hobart J;
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S56-60. PubMed ID: 23391006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.
    Braskie MN; Thompson PM
    Biol Psychiatry; 2014 Apr; 75(7):527-33. PubMed ID: 24367935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.
    Gibbons LE; Carle AC; Mackin RS; Harvey D; Mukherjee S; Insel P; Curtis SM; Mungas D; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):517-27. PubMed ID: 22644789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.
    Iwatsubo T
    Alzheimers Dement; 2010 May; 6(3):297-9. PubMed ID: 20451880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
    Hendrix JA; Finger B; Weiner MW; Frisoni GB; Iwatsubo T; Rowe CC; Kim SY; Guinjoan SM; Sevlever G; Carrillo MC
    Alzheimers Dement; 2015 Jul; 11(7):850-9. PubMed ID: 26194318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Iwatsubo T; Iwata A; Suzuki K; Ihara R; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; ; Sun CK; Beckett LA; Petersen RC; Weiner MW; Aisen PS; Donohue MC;
    Alzheimers Dement; 2018 Aug; 14(8):1077-1087. PubMed ID: 29753531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Donohue MC; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw L; Thompson PM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2015 Jul; 11(7):865-84. PubMed ID: 26194320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
    Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
    EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses.
    Rouch L; Virecoulon Giudici K; Cantet C; Guyonnet S; Delrieu J; Legrand P; Catheline D; Andrieu S; Weiner M; de Souto Barreto P; Vellas B;
    Am J Clin Nutr; 2022 Dec; 116(6):1492-1506. PubMed ID: 36253968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
    Jones-Davis DM; Buckholtz N
    Alzheimers Dement; 2015 Jul; 11(7):860-4. PubMed ID: 26194319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creation of the Argentina-Alzheimer's Disease Neuroimaging Initiative.
    Russo MJ; Gustafson D; Vázquez S; Surace E; Guinjoan S; Allegri RF; Sevlever G;
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S84-7. PubMed ID: 24864324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.